Not everyone in the health field is so bullish on the prospects of CGMs for everyone, and question whether digging in too ...
Abbott Laboratories narrowed its full-year profit outlook, raising the midpoint slightly, as strong demand for its diabetes ...
With an in-line performance expected in Q3, ABT stock may trade sideways next week. However, we would watch out for its ...
To meet international guidelines, New Zealand needs to double the workforce that supports people with diabetes. Unless that ...
There are problems within the health system that mean full patient access to training on how to use the insulin pumps will ...
Continuous glucose monitors (CGM), once exclusive to diabetics, are now available over-the-counter, opening new possibilities ...
Pharmac's decision to fund continuous glucose monitors and automated insulin delivery systems for the approximately 18,000 people who currently live ...
Abbott Laboratories slightly lifted its annual profit forecast on Wednesday, after beating Wall Street estimates for ...
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for ...
(Reuters) - Abbott Laboratories slightly lifted its annual profit forecast on Wednesday, after beating Wall Street estimates ...
The Apple Watch has long been the Bad Bad Leroy Brown of smartwatches (baddest man in the whole damned town). The new Series ...